Semiconductor ETF Market Vectors (SMH) 55.30 $SMH The

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Semiconductor ETF Market Vectors (SMH) 55.30 $SMH

The Zacks Analyst Blog Highlights: Market Vectors Semiconductor ETF, iShares PHLX Semiconductor ETF, PowerShares Dynamic Semiconductors Fund and SPDR S&P Semiconductor ETF - Press Releases
Zacks Equity Research - Zacks Investment Research - Tue Mar 31, 8:30AM CDT
The Zacks Analyst Blog Highlights: Market Vectors Semiconductor ETF, iShares PHLX Semiconductor ETF, PowerShares Dynamic Semiconductors Fund and SPDR S&P Semiconductor ETF
PSI: 27.00 (-0.32), SOXX: 94.02 (-1.07), SMH: 55.30 (-0.56), XSD: 87.68 (-1.05)

Semiconductor ETFs To Watch Should Intel Buy Altera
Zacks Funds - Seeking Alpha - Tue Mar 31, 6:39AM CDT
Wall Street is speculating that the world's largest chipmaker Intel Corp. (NASDAQ: INTC ) is in talks to buy fellow chipmaker Altera Corp. (NASDAQ: ALTR ). According to sources, the deal will likely be valued at over $10 billion. The timing and terms...
PSI: 27.00 (-0.32), ALTR: 42.91 (+0.09), SOXX: 94.02 (-1.07), SMH: 55.30 (-0.56), INTC: 31.27 (-0.19), XSD: 87.68 (-1.05)

Semiconductor ETFs to Watch Should Intel Buy Altera - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Mon Mar 30, 10:00AM CDT
The speculation of Altera takeover by Intel has put the semiconductor ETFs in focus over the coming days.
PSI: 27.00 (-0.32), ALTR: 42.91 (+0.09), NXPI: 100.36 (-2.07), SOXX: 94.02 (-1.07), SMH: 55.30 (-0.56), INTC: 31.27 (-0.19), HPQ: 31.16 (-0.41), XSD: 87.68 (-1.05)

Selloff In Biotech, Semiconductor ETFs: A Nice Entry Point?
Zacks Funds - Seeking Alpha - Sun Mar 29, 12:29PM CDT
The U.S. stock market suffered the steepest decline in the Wednesday trading session, as concerns over the lofty valuations in biotech and semiconductors unnerved investors. In addition, a surprise drop in durable goods, Middle East tensions, and...
SBIO: 29.87 (-0.25), BBC: 32.83 (-0.63), PSI: 27.00 (-0.32), XBI: 225.50 (+1.13), SMH: 55.30 (-0.56), SOXX: 94.02 (-1.07), XSD: 87.68 (-1.05)

Chip stocks rally on Intel/Altera report
Seeking Alpha - at Seeking Alpha - Fri Mar 27, 3:54PM CDT

SOXS: 11.81 (+0.35), MXIM: 34.81 (-0.16), SYNA: 81.30 (-1.12), SOXL: 136.04 (-4.96), INVN: 15.21 (-0.31), TSM: 23.48 (+0.23), FCS: 18.18 (-0.60), SOXX: 94.02 (-1.07), SMH: 55.30 (-0.56), SSG: 47.97 (+1.25), PSI: 27.00 (-0.32), USD: 89.21 (-2.06), QUIK: 1.93 (+0.03), ADI: 63.00 (-1.81), CRUS: 33.26 (+0.06), AVGO: 126.98 (-3.57), XSD: 87.68 (-1.05)

Jim Cramer -- There's No Bubble in Biotech or Semiconductor Sectors
at The Street - Fri Mar 27, 10:23AM CDT
Some of Cramer's favorite companies are rising with their sectors Friday.
BIIB: 422.24 (-9.38), QRVO: 79.70 (-1.70), SWKS: 98.29 (-1.84), IBB: 343.43 (-7.89), SMH: 55.30 (-0.56), NXPI: 100.36 (-2.07), REGN: 451.48 (-8.30), AVGO: 126.98 (-3.57), CELG: 115.28 (-4.74)

Semiconductors' Continued Fall May Foreshadow Deeper Problems
at The Street - Fri Mar 27, 4:00AM CDT
Micron's stock price is down 30% from its high; an analyst downgrades automaker Tesla.
MU: 27.13 (+0.45), QCOM: 69.34 (+0.46), SMH: 55.30 (-0.56), INTC: 31.27 (-0.19)

Chip stocks slump again after SanDisk warns; TSMC remarks in focus
Seeking Alpha - at Seeking Alpha - Thu Mar 26, 9:50AM CDT

SOXS: 11.81 (+0.35), AMBA: 75.71 (+1.10), CAVM: 70.82 (-1.93), AIXG: 7.52 (-0.07), SWKS: 98.29 (-1.84), VECO: 30.55 (+0.09), SOXL: 136.04 (-4.96), TSM: 23.48 (+0.23), SMH: 55.30 (-0.56), SOXX: 94.02 (-1.07), NXPI: 100.36 (-2.07), ACLS: 2.38 (-0.02), SSG: 47.97 (+1.25), KLIC: 15.63 (-0.20), PSI: 27.00 (-0.32), QRVO: 79.70 (-1.70), USD: 89.21 (-2.06), FSL: 40.76 (-0.72), STM: 9.27 (-0.16), XSD: 87.68 (-1.05)

Sell-Off in Biotech, Semiconductor ETFs: A Nice Entry Point? - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Thu Mar 26, 9:00AM CDT
Given bullish fundamentals, the current beaten down prices for biotech and semiconductor ETFs could be viewed as a buying opportunity.
SBIO: 29.87 (-0.25), BBC: 32.83 (-0.63), PSI: 27.00 (-0.32), XBI: 225.50 (+1.13), SMH: 55.30 (-0.56), SOXX: 94.02 (-1.07), XSD: 87.68 (-1.05)

'Fast Money' Recap: The 3 Reasons Stocks Tanked Wednesday
at The Street - Thu Mar 26, 4:00AM CDT
The trading panel discussed the declines in biotech, transports and semiconductors.
FDX: 165.45 (-1.30), BIIB: 422.24 (-9.38), MU: 27.13 (+0.45), OIH: 33.71 (-0.19), XBI: 225.50 (+1.13), AMGN: 159.85 (-4.45), BNO: 20.50 (-0.43), IBB: 343.43 (-7.89), SMH: 55.30 (-0.56), INTC: 31.27 (-0.19), TLT: 130.69 (+0.28), CELG: 115.28 (-4.74), NVDA: 20.92 (-0.55), SAN: 7.45 (-0.05), SAVE: 77.36 (-0.94), GILD: 98.13 (-2.56), QCOM: 69.34 (+0.46), IYT: 156.62 (-0.84)

Semiconductor HOLDRs Trust Set to Possibly Rebound After Yesterday's Selloff of 4.67%
Comtex SmarTrend(R) - Wed Mar 25, 4:20PM CDT
Semiconductor HOLDRs Trust (AMEX:SMH) traded in a range yesterday that spanned from a low of $53.97 to a high of $56.73. Yesterday, the shares fell 4.7%, which took the trading range below the 3-day low of $56.72 on volume of 10.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SMH: 55.30 (-0.56)

Watch for Semiconductor HOLDRs Trust to Potentially Rebound After Falling 4.67% Yesterday
Comtex SmarTrend(R) - Wed Mar 25, 4:20PM CDT
Semiconductor HOLDRs Trust (AMEX:SMH) traded in a range yesterday that spanned from a low of $53.97 to a high of $56.73. Yesterday, the shares fell 4.7%, which took the trading range below the 3-day low of $56.72 on volume of 10.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SMH: 55.30 (-0.56)

Semiconductor HOLDRs Trust Falls 4.67% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Mar 25, 4:19PM CDT
Semiconductor HOLDRs Trust (AMEX:SMH) traded in a range yesterday that spanned from a low of $53.97 to a high of $56.73. Yesterday, the shares fell 4.7%, which took the trading range below the 3-day low of $56.72 on volume of 10.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SMH: 55.30 (-0.56)

Chip stocks off sharply
Seeking Alpha - at Seeking Alpha - Wed Mar 25, 11:03AM CDT

MXIM: 34.81 (-0.16), AMCC: 5.10 (-0.16), MTSN: 3.94 (+0.10), ATML: 8.23 (-0.26), ADNC: 4.54 (+0.04), TSRA: 40.28 (-0.05), TSEM: 16.98 (-0.05), XSD: 87.68 (-1.05), CREE: 35.49 (+0.09), SOXS: 11.81 (+0.35), AMBA: 75.71 (+1.10), CAVM: 70.82 (-1.93), MU: 27.13 (+0.45), CY: 14.11 (unch), SWKS: 98.29 (-1.84), LSCC: 6.34 (-0.12), SOXL: 136.04 (-4.96), LLTC: 46.80 (-0.79), TSM: 23.48 (+0.23), SMH: 55.30 (-0.56), NXPI: 100.36 (-2.07), SOXX: 94.02 (-1.07), IDTI: 20.02 (-0.40), ISIL: 14.32 (-0.05), UTEK: 17.34 (-0.56), ASML: 101.03 (-2.09), SSG: 47.97 (+1.25), NVDA: 20.92 (-0.55), PSI: 27.00 (-0.32), QRVO: 79.70 (-1.70), LRCX: 70.23 (-1.96), AMD: 2.68 (-0.02), USD: 89.21 (-2.06), ARMH: 49.30 (-0.29), KLAC: 58.29 (-1.11), FSL: 40.76 (-0.72), STM: 9.27 (-0.16), AVGO: 126.98 (-3.57)

What Wall Street Doesn't Want You To Know: The Foolishness Of Chasing The Most Popular Themes
Robert Duval - at Seeking Alpha - Tue Mar 17, 6:43PM CDT

TSLA: 188.77 (-1.80), MU: 27.13 (+0.45), EBAY: 57.68 (-0.24), GILD: 98.13 (-2.56), IBB: 343.43 (-7.89), SMH: 55.30 (-0.56), EPHE: 41.60 (-0.44)

Intel Sales Warning Puts Semiconductor ETFs In Focus
Zacks Funds - Seeking Alpha - Mon Mar 16, 5:50AM CDT
The beginning of 2015 saw no let-off to the semiconductor rally that started last year as industry fundamentals remained strong and investors continued to prefer value-centric traditional stocks. However, the industry witnessed some pull backs on not...
PSI: 27.00 (-0.32), SOXX: 94.02 (-1.07), SMH: 55.30 (-0.56), INTC: 31.27 (-0.19), XSD: 87.68 (-1.05)

Intel Sales Warning Puts Semiconductor ETFs in Focus - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Fri Mar 13, 9:00AM CDT
It seems Intel's tough ride cannot halt the rally in semiconductor ETFs.
PSI: 27.00 (-0.32), SOXX: 94.02 (-1.07), SMH: 55.30 (-0.56), INTC: 31.27 (-0.19), XSD: 87.68 (-1.05)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 36

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 41

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 36

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 32

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

AgEagle Aerial Systems Welcomes Kevin Lowdermilk to the Board

Updated Category News Views 103

AgEagle Aerial Systems Welcomes Kevin Lowdermilk to the Board AgEagle Aerial Systems Inc. (NYSE: UAVS), renowned for its top-tier unmanned aerial systems (UAS), is excited to announce the recent addition of Kevin Lowdermilk to its board of directors. His appointment, effective as of late October, marks a strategic enhancement to the company's leadership team, ensuring...

Continue Reading
Natera's Growth Continues Amid Legal Challenges and Market Wins

Updated Category News Views 413

Natera Faces Legal Challenges with Strong Market Performance Natera, Inc. (NASDAQ: NTRA) is a leader in the genetic testing industry, known for its groundbreaking contributions to oncology and women’s health. Recently, the company encountered an unfavorable jury decision in a legal battle concerning false advertising claims made against Guardant Health (NASDAQ: GH). The...

Continue Reading
Spreedly Sees Unprecedented Growth in Open Payments Sector

Updated Category News Views 110

Spreedly Surges Ahead in Open Payments Innovation Spreedly, a prominent leader in open payments, has recently showcased remarkable progress in revenue and customer expansion, marking a new chapter in the payment processing industry. With a growing clientele that spans across varied sectors, the company is redefining how digital transactions are handled worldwide. Key...

Continue Reading
Shelley Joyce Takes the Helm as CTO at TSG, Ramping Up Innovation

Updated Category News Views 431

TSG Appoints Shelley Joyce as New Chief Technology Officer In a significant move to enhance its technology initiatives, TSG (The Strawhecker Group) has announced the appointment of Shelley Joyce as the Chief Technology Officer (CTO). With her extensive background in the payments industry, Shelley is set to lead TSG’s technological advancements and cater to the evolving...

Continue Reading
Equillium Plans Engaging Event for Ulcerative Colitis Insights

Updated Category News Views 121

Equillium's Upcoming Event on Ulcerative Colitis Equillium, Inc. (NASDAQ: EQ), a biotechnology company focused on developing innovative therapeutics for autoimmune and inflammatory diseases, has announced an exciting virtual event featuring prominent thought leaders in the field of ulcerative colitis (UC). This event is scheduled for a Wednesday in November at 12 PM ET....

Continue Reading